Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
“The gastrointestinal stents market is projected to grow at a CAGR of 5.1% between 2017 and 2022.”
The gastrointestinal stents market is expected to reach USD 452.6 million by 2022 from USD 353.4 million in 2017, at a CAGR of 5.1% from 2017 to 2022. The rising prevalence of gastrointestinal cancers and other digestive diseases and the rising preference for minimally invasive procedures are some of the major factors driving the growth of this market. However, complications associated with gastrointestinal stent implementation are limiting the adoption of these stents.
“Pancreatic stents segment to witness the highest growth rate during the forecast period.”
On the basis of product, the pancreatic stents segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing number of endoscopic retrograde cholangiopancreatography procedures and the rising prevalence of acute pancreatitis.
“Self-expanding metal stents segment to grow at the highest CAGR from 2017 to 2022.”
Based on material, the self-expanding metal stents segment is expected to grow at the highest CAGR during the forecast period. The increasing adoption of these stents by hospitals and ASCs for the treatment of gastrointestinal diseases is the major factor supporting its growth during the forecast period.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapidly developing healthcare industry in China and India, growth in aging population, rising life expectancy and per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, availability of low-cost labor, and presence of a favorable regulatory environment.
Break of primary participants:
• By Company Type – Tier 1: 46%, Tier 2–33%, and Tier 3–21%
• By Designation – C Level: 43%, Director Level: 35%, and Others: 22%
• By Region – North America: 28%, Europe: 34%, Asia Pacific: 22%, Latin America: 14%, and the Middle East & Africa: 6%
The report analyzes the various gastrointestinal stents and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global gastrointestinal stents market for different segments such as product, material, disease type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the gastrointestinal stents market
Product Development/Innovation: Detailed insights on research and development activities and new product launches in the gastrointestinal stents market
Market Development: Comprehensive information about lucrative emerging markets, by product, material, disease type, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, recent developments in the gastrointestinal stents market
Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the gastrointestinal stents market